DEC-net: The development of the European register of clinical trials on medicines for children

Eugenio Santoro, Valentina Rossi, Chiara Pandolfini, Maurizio Bonati

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: The need to register a clinical trial in a public database has been widely discussed in the last few years. Several general clinical trial registers have been developed, but none are dedicated to children. A web-based register of trials on drug therapy in children was therefore developed. Purpose: The general objective of the project, called DEC-NET (European register of clinical trials on medicines for children - drug evaluation in children) and supported by the European Community, is to provide the scientific community with a flexible tool for promoting communication and collaboration among researchers, disseminating clinical trial results and facilitating patient access and recruitment to trials. Methods: We identified a set of trial data to be collected, including general trial information, recruitment information, eligibility criteria, clinical trial characteristics, location and contact information, study drugs, study sponsor and results. The system was set up to allow authorized users (working in Italy, Spain, France and UK) to enter, handle and monitor the trial information. Medical data dictionaries (ie, ICD-9 and ATC) were used in order to make the data-entry and the search and data analysis procedures easier. A multilingual approach in data handling and presentation made accessing trial information in English and in the language of the country where the study is located feasible. Search and browsing tools were set up to allow investigators, researchers, and citizens to freely search and browse the entire register and access the details of trials meeting the search criteria. Results: The DEC-net register (http://www.dec-net.org) was opened for trial notification and consultation. Limitations: DEC-net currently involves four European countries and is a pilot project. Conclusions: It is hoped that what has been achieved so far represents only the beginning of a long-term project, and the next step will be to extend the register's use to other European countries.

Original languageEnglish
Pages (from-to)366-375
Number of pages10
JournalClinical Trials
Volume3
Issue number4
DOIs
Publication statusPublished - 2006

Fingerprint

Clinical Trials
Research Personnel
Medical Dictionaries
Drug Evaluation
International Classification of Diseases
European Union
Spain
Patient Selection
Italy
France
Language
Referral and Consultation
Communication
Databases
Drug Therapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

DEC-net : The development of the European register of clinical trials on medicines for children. / Santoro, Eugenio; Rossi, Valentina; Pandolfini, Chiara; Bonati, Maurizio.

In: Clinical Trials, Vol. 3, No. 4, 2006, p. 366-375.

Research output: Contribution to journalArticle

@article{66fca3058a314bb78a679b2920f09433,
title = "DEC-net: The development of the European register of clinical trials on medicines for children",
abstract = "Background: The need to register a clinical trial in a public database has been widely discussed in the last few years. Several general clinical trial registers have been developed, but none are dedicated to children. A web-based register of trials on drug therapy in children was therefore developed. Purpose: The general objective of the project, called DEC-NET (European register of clinical trials on medicines for children - drug evaluation in children) and supported by the European Community, is to provide the scientific community with a flexible tool for promoting communication and collaboration among researchers, disseminating clinical trial results and facilitating patient access and recruitment to trials. Methods: We identified a set of trial data to be collected, including general trial information, recruitment information, eligibility criteria, clinical trial characteristics, location and contact information, study drugs, study sponsor and results. The system was set up to allow authorized users (working in Italy, Spain, France and UK) to enter, handle and monitor the trial information. Medical data dictionaries (ie, ICD-9 and ATC) were used in order to make the data-entry and the search and data analysis procedures easier. A multilingual approach in data handling and presentation made accessing trial information in English and in the language of the country where the study is located feasible. Search and browsing tools were set up to allow investigators, researchers, and citizens to freely search and browse the entire register and access the details of trials meeting the search criteria. Results: The DEC-net register (http://www.dec-net.org) was opened for trial notification and consultation. Limitations: DEC-net currently involves four European countries and is a pilot project. Conclusions: It is hoped that what has been achieved so far represents only the beginning of a long-term project, and the next step will be to extend the register's use to other European countries.",
author = "Eugenio Santoro and Valentina Rossi and Chiara Pandolfini and Maurizio Bonati",
year = "2006",
doi = "10.1177/1740774506069154",
language = "English",
volume = "3",
pages = "366--375",
journal = "Clinical Trials",
issn = "1740-7745",
publisher = "SAGE Publications Ltd",
number = "4",

}

TY - JOUR

T1 - DEC-net

T2 - The development of the European register of clinical trials on medicines for children

AU - Santoro, Eugenio

AU - Rossi, Valentina

AU - Pandolfini, Chiara

AU - Bonati, Maurizio

PY - 2006

Y1 - 2006

N2 - Background: The need to register a clinical trial in a public database has been widely discussed in the last few years. Several general clinical trial registers have been developed, but none are dedicated to children. A web-based register of trials on drug therapy in children was therefore developed. Purpose: The general objective of the project, called DEC-NET (European register of clinical trials on medicines for children - drug evaluation in children) and supported by the European Community, is to provide the scientific community with a flexible tool for promoting communication and collaboration among researchers, disseminating clinical trial results and facilitating patient access and recruitment to trials. Methods: We identified a set of trial data to be collected, including general trial information, recruitment information, eligibility criteria, clinical trial characteristics, location and contact information, study drugs, study sponsor and results. The system was set up to allow authorized users (working in Italy, Spain, France and UK) to enter, handle and monitor the trial information. Medical data dictionaries (ie, ICD-9 and ATC) were used in order to make the data-entry and the search and data analysis procedures easier. A multilingual approach in data handling and presentation made accessing trial information in English and in the language of the country where the study is located feasible. Search and browsing tools were set up to allow investigators, researchers, and citizens to freely search and browse the entire register and access the details of trials meeting the search criteria. Results: The DEC-net register (http://www.dec-net.org) was opened for trial notification and consultation. Limitations: DEC-net currently involves four European countries and is a pilot project. Conclusions: It is hoped that what has been achieved so far represents only the beginning of a long-term project, and the next step will be to extend the register's use to other European countries.

AB - Background: The need to register a clinical trial in a public database has been widely discussed in the last few years. Several general clinical trial registers have been developed, but none are dedicated to children. A web-based register of trials on drug therapy in children was therefore developed. Purpose: The general objective of the project, called DEC-NET (European register of clinical trials on medicines for children - drug evaluation in children) and supported by the European Community, is to provide the scientific community with a flexible tool for promoting communication and collaboration among researchers, disseminating clinical trial results and facilitating patient access and recruitment to trials. Methods: We identified a set of trial data to be collected, including general trial information, recruitment information, eligibility criteria, clinical trial characteristics, location and contact information, study drugs, study sponsor and results. The system was set up to allow authorized users (working in Italy, Spain, France and UK) to enter, handle and monitor the trial information. Medical data dictionaries (ie, ICD-9 and ATC) were used in order to make the data-entry and the search and data analysis procedures easier. A multilingual approach in data handling and presentation made accessing trial information in English and in the language of the country where the study is located feasible. Search and browsing tools were set up to allow investigators, researchers, and citizens to freely search and browse the entire register and access the details of trials meeting the search criteria. Results: The DEC-net register (http://www.dec-net.org) was opened for trial notification and consultation. Limitations: DEC-net currently involves four European countries and is a pilot project. Conclusions: It is hoped that what has been achieved so far represents only the beginning of a long-term project, and the next step will be to extend the register's use to other European countries.

UR - http://www.scopus.com/inward/record.url?scp=33750436197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750436197&partnerID=8YFLogxK

U2 - 10.1177/1740774506069154

DO - 10.1177/1740774506069154

M3 - Article

C2 - 17060211

AN - SCOPUS:33750436197

VL - 3

SP - 366

EP - 375

JO - Clinical Trials

JF - Clinical Trials

SN - 1740-7745

IS - 4

ER -